SMAD2 and idiopathic pulmonary arterial hypertension: In LRP1-deficient mice with IPAH and PASMCs from IPAH patients, treatment with pioglitazone activates PPARγ, allowing it to bind to Smad2 and compensate for the lack of LRP1408 (Table 1).